Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (19)

2024

  1. Corrigendum to “Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis” [Psychoneuroendocrinology 150 (2023) 106049] (Psychoneuroendocrinology (2023) 150, (S0306453023000276), (10.1016/j.psyneuen.2023.106049))

    Psychoneuroendocrinology

2023

  1. Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review

    European Child and Adolescent Psychiatry

  2. Point of care assay for blood aripiprazole concentrations: Development, validation and utility

    British Journal of Psychiatry, Vol. 223, Núm. 2, pp. 389-393

  3. Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis

    Psychoneuroendocrinology, Vol. 150

  4. Psychological impact of COVID-19 lockdown on a population with serious mental illness. A prospective cohort study

    Revista de Psiquiatria y Salud Mental, Vol. 16, pp. 59-67

  5. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

  6. Relationship between elimination disorders and internalizing-externalizing problems in children: A systematic review and meta-analysis

    JCPP Advances, Vol. 3, Núm. 3

2022

  1. COVID-19 pandemic effects on health worker's mental health: Systematic review and meta-analysis

    European Psychiatry, Vol. 65, Núm. 1

  2. Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis

    Translational Psychiatry, Vol. 12, Núm. 1

2021

  1. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis

    Early Intervention in Psychiatry, Vol. 15, Núm. 6, pp. 1584-1594

  2. Implementing Precision Psychiatry: A Systematic Review of Individualized Prediction Models for Clinical Practice

    Schizophrenia Bulletin, Vol. 47, Núm. 2, pp. 284-297

  3. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis

    JAMA Psychiatry, Vol. 78, Núm. 8, pp. 859-867

  4. Proportion and predictors of remission and recovery in first-episode psychosis: Systematic review and meta-analysis

    European Psychiatry, Vol. 64, Núm. 1

2020

  1. Can childhood trauma influence facial emotion recognition independently from a diagnosis of severe mental disorder?

    Revista de Psiquiatria y Salud Mental, Vol. 13, Núm. 3, pp. 140-149

  2. Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment

    JAMA Psychiatry, Vol. 77, Núm. 3, pp. 311-320

  3. Genetic modulation of facial emotion recognition in borderline personality disorder

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 99

2019

  1. GAD1 gene polymorphisms are associated with bipolar I disorder and with blood homovanillic acid levels but not with plasma GABA levels

    Neurochemistry International, Vol. 124, pp. 152-161

2018

  1. Affectively salient signal to random noise might be used to identify psychosis vulnerability in severe mental disorders

    European Psychiatry, Vol. 49, pp. 37-42

  2. The relationship between theory of mind deficits and neurocognition in first episode-psychosis

    Psychiatry Research, Vol. 268, pp. 361-367